Guideline Adherence and Practice Patterns in the Management of Medullary Thyroid Cancer

Nicholas A Frisco1, Alexander H Gunn1, Frances Wang2

  • 1Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Abstract

Insights

Adherence to 2015 American Thyroid Association guidelines for medullary thyroid cancer (MTC) management improved post-2015. Guideline-concordant care is linked to better survival outcomes for localized and regional MTC patients.

Area of Science:

  • Endocrinology
  • Oncology
  • Surgical Oncology

Background:

  • Nationwide practice patterns for medullary thyroid cancer (MTC) management and their impact on survival in relation to the 2015 American Thyroid Association (ATA) guidelines are not well understood.
  • Evaluating treatment trends and outcomes is crucial for optimizing patient care.

Purpose of the Study:

  • To assess nationwide practice patterns for medullary thyroid cancer (MTC) management.
  • To evaluate adherence to the 2015 American Thyroid Association (ATA) guidelines.
  • To determine the impact of guideline-concordant care on survival outcomes.

Main Methods:

  • Utilized the Surveillance, Epidemiology, and End Results (SEER) Program database (2000-2018) to identify 3332 MTC patients.
  • Analyzed treatment patterns across three time periods: 2000-2009, 2010-2015, and 2016-2018.
  • Assessed guideline concordance, treatment utilization, disease-specific survival (DSS), and overall survival (OS).

Main Results:

  • Guideline-concordant surgery rates for locoregional MTC increased from 63.0% (2000-2009) to 76.0% (2016-2018).
  • Guideline-concordant care was associated with improved overall survival (OS) in localized disease and both disease-specific survival (DSS) and OS in regional disease.
  • For distant MTC, median OS was 31 months and median DSS was 55 months, with a rise in chemotherapy use from 21.6% to 39.2%.

Conclusions:

  • The rate of guideline-concordant surgery for locoregional MTC has increased since the 2015 ATA guideline publication.
  • Guideline-concordant care is associated with prolonged OS and DSS.
  • While chemotherapy use has increased for distant MTC, prognosis remains variable.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17